Director of YNU's Affiliated Hospital awarded national honor

Xing Xiqian, director of the Department of Respiratory and Critical Care Medicine at the Affiliated Hospital Yunnan University (YNU), was recently recognized as a National Outstanding Young Physician in the inaugural National High-Level Medical Talent Program. He is the only physician from Southwest China’s Yunnan province to receive this recognition.

Xing (center in cyan) provides technical guidance to a team. [Photo/WeChat account of Yunnan University]

The National Health Commission and the Ministry of Finance released the list after a rigorous selection process that included provincial and municipal recommendations, online reviews, expert evaluations, and public disclosures. A total of 100 doctors were named National Distinguished Physicians, and 200 were honored as National Outstanding Young Physicians.

Xing holds key positions in prestigious medical organizations. He is a member of the Respiratory Physicians Branch of the Chinese Medical Doctor Association, the Respiratory Disease Branch of the Chinese Preventive Medicine Association, and the vice-chairman of the Respiratory Disease Branch of the Yunnan Medical Association.

He has significantly contributed to clinical research on pulmonary circulation, vascular diseases, and interventional respiratory medicine. As the leader of Yunnan's Respiratory and Pulmonary Circulation Disease Innovation Team, he heads a key laboratory under the Yunnan Provincial Department of Education. He also leads a major provincial pilot project integrating traditional Chinese and Western medicine for complex diseases.

Xing is recognized for his excellence in technological innovation and research application. He has published over 130 academic papers, has led five projects funded by the National Natural Science Foundation, and received six provincial research grants. His achievements include two provincial and ministerial-level Science and Technology Progress Awards and 15 national patents. He also mentors Yunnan University, Kunming Medical University, and Dali University graduate students and has contributed to 17 international and national clinical guidelines.

Under his leadership, his team has made remarkable strides in interventional respiratory medicine, particularly in treating central airway stenosis, giant pulmonary bullae, bronchopleural fistulas, pulmonary hypertension, and pulmonary nodules.